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Abstract. Simulation of hypoperfusion of the right uterine horn in rats on the 14
th
 day of pregnancy 
resulted in disruption of microcirculation in placentas of the left uterine horn, decrease of fetal 
weight and length as well as in fetal death after implantation.  
The obtained data complement the overall understanding of the pathogenesis of preeclampsia and 
placental insufficiency and create preconditions for development of new areas of creation of 
effective drugs for treatment and prevention of these pathologies. 
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Introduction 
Preeclampsia is the most frequent disease of 
pregnant women and holds the first place among the 
reasons of maternal and perinatal mortality. The 
pathogenesis of this severe disease is still far from 
being understood completely. However in recent 
years many authors report a specific histological 
pattern at time of morphological examination of the 
placenta, i.e. disproportional development of the 
marginal area between the maternal and the fetal 
portions [1, 21, 24, 28]. There has been observed 
incomplete invasion of cytotrophoblast into the 
coiled artery of the uterus. In case of gestosis the 
level of alteration of the coiled arteries themselves 
does not reach the level specific to normal pregnancy 
[18, 26, 27]. Increased distance between the coiled 
arteries and the chorionic villae as well as immaturity 
of the coiled arteries themselves induces trophoblast 
ischemia and the fetoplacental barrier permeability 
increase.  
The produced humoral factors in response to 
ischemia as well as possibly to fetal antigens which 
passed through the fetoplacental barrier with the 
increased permeability after penetration into a 
maternal body encourage accumulation of 
asymmetric dimethylarginine (ADMA) in plasma, 
development of generalized endothelial dysfunction, 
secondary ischemic events and oxidative stress [5, 6, 
7, 14, 15, 16, 16]. Due to the above search of new 
medicinal preparations for treatment and prevention 
of preeclampsia which would have 
endothelioprotective, anti-ischemic and antioxidant 
activity becomes of great importance [1, 5, 11, 12, 
23, 25]. However the information on the influence of 
the humoral factors released by the hypoperfused 
placenta on fetal development and healthy portions of 
the placenta in the available literature is rather scarce. 
In this connection the presented work was dedicated 
to research of fetal development and the state of 
placenta under the conditions of placental 
hypoperfusion modeling.   
Research objective: To study the peculiarities 
of fetal development and the state of placenta under 
the conditions of hypoperfusion modeling in rats.  
Research methodology 
The experiment involved 20 white female 
Wistar rats with the weight of 250–300 g. In order to 
form groups of pregnant animals with the specific 
gestational age male rats (2 animals) were introduced 
into a cage with female rats (3 animals) for the period 
of 24 hours, at that the animals before the experiment 
were maintained in separate cages. After that the 
animals were caged in separate cages and after the 
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period of 14 days pregnancy was established by 
palpation under the ether narcosis conditions. Our 
experiments showed 30-40% of pregnancy event 
frequency. The pregnant rats were divided into the 
groups (n=10): I – intact; II – with modeling of 
hypoperfusion in the right uterine horn on the 14
th
 
day of gestation. A model of the uterine 
hypoperfusion as described by many authors 
(Ошибка! Источник ссылки не найден., 
Ошибка! Источник ссылки не найден., 
Ошибка! Источник ссылки не найден.) and 
modified by us was taken as a prototype. On the 14
th
 
day of gestation 10 animals underwent surgery 
involving application of silver clamps on the right 
iliac artery (0.2 mm) and the right ovarial artery (0.1 
mm). Thus we’ve ensured hypoperfusion only in the 
right uterine horn in contrast to the described 
prototype.   
On the 21
st
 day of gestation in order to register 
the indices of systolic and diastolic blood pressure 
(SBP, DBP) catheterization of the right carotid artery 
of the anesthetized (chloral hydrate in the dose of 300 
mg/kg) animals was performed, bolus dosing of 
pharmacological substances was carried out into the 
right femoral vein. There were performed vascular 
tests in order to determine endothelium-dependent 
and endothelium-independent vasodilatation along 
with calculation of an endothelial dysfunction 
coefficient (EDC) [9].  
The study of the placental microcirculation was 
made with the aid of the equipment produced by 
«Biopac systems» company: a polygraph MP100 
with a laser Doppler flowmetry module (LDF) 
LDf100C and a sensor TSD144. The LDF results 
recording was performed by means of the program 
Acqknowledge of 3.8.1 version, the values of 
microcirculation were expressed in perfusion units 
(PU) [2, 3, 4]. NO-production function of 
endothelium was assessed on the basis of the data on 
the content of stable NO metabolites, i.e. nitrite ions 
(NOx) in blood plasma. For the purpose of 
determining fluid content in the greater omentum the 
same was weighted, dried at the temperature of 37
0С 
within the period of 24 hours and weighed once again 
[8, 13]. 
Results and discussion 
Application of the clamps on the right iliac 
artery and the right ovarial artery did not resulted in 
the statistically significant change of the blood 
pressure and the endothelial dysfunction coefficient 
(Table 1). The animals in this group demonstrated 
decrease of the placental microcirculation from 
452.4±27.16 to 204.4±14.30 PU in the right uterine 
horn and to 309.0±15.80 PU in the left uterine horn 
(p<0.05). No statistically significant change of 
diuresis, proteinuria and NO-synthesizing function of 
endothelium was observed in these animals.  
Modeling of reduced blood flow in the placentas 
of the right uterine horn produced changes of 
ischemic genesis, i.e. there were observed extensive 
necroses and hemorrhages in the labyrinth zone, 
tissues dissection on the border between the placenta 
and the uterine wall (partial separation).  
The comparative evaluation of the state of 
fetuses revealed reduction of the fetal weight and size 
as compared to the group of intact pregnant animals 
and post-implantation fetal death.  
Table 1 
The values of morphological and functional parameters 
in pregnant rats at time of modeling the reduced blood 
flow in the right uterine horn 
(M±m; n=10) 
Group 
Parameter 
Pregnant 
(intact) 
Pregnant 
(hypoperfusion of 
the right uterine 
horn) 
SBP, mm hg 134.5±2.3 138.8±4.4 
DBP, mm hg 92.0±2.1 89.8±5.7 
EDC, c.u. 1.10±0.11 1.29±0.08 
Microcirculation, 
PU 
446.3±27.46 204.4±14.30*R 
309.0±15.80*L 
NOx, micromole/dL 2.28±0.11 2.15±0.09* 
Fluid content in the 
greater omentum 
tissues, % 
49.89±0.82 48.78±2.00 
Weigh of fetuses, g 1.73±0.06 1.13±0.06*R 
1.31±0.08*L 
Length of fetuses, 
mm 
24.59±0.42 20.89±0.45*R 
22.90±0.45*L 
Lwngth/weight, 
mm/g 
14.91±0.28 19.36±0.76*R 
18.63±0.68*L 
Post-implantation 
death, % 
0 34.16±3.37*R 
18.66±5.66*L 
Note: SBP, DBP – systolic and diastolic blood 
pressure (mm hg); EDC – endothelial dysfunction 
coefficient (c.u.); microcirculation in the placenta (PU); 
nitrite ions concentration (NOx); 
*
- р < 0.05 as compared 
to the intact animals group; R – the right uterine horn; L – 
the left uterine horn. 
Therefore the results of the carried out 
experiment give evidence of the absence of marked 
effect of the right uterine horn hypoperfusion on 
systemic hemodynamic values. The local changes in 
the right uterine horn are expected and in line with 
the literature data. The changes observed in the left 
uterine horn blood supplying vessels of which remain 
intact have the biggest importance. To all seeming 
the humoral factors released by the ischemic placenta 
of the right uterine horn [23] have local marked effect 
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on the intact placenta vessels since they are the most 
sensitive. 
On the basis of the obtained data in relation to 
the pathogenesis of development of preeclamsia and 
placental insufficiency it is possible to state with 
some degree of certainty that the areas of ischemic 
placenta may induce deterioration of morphological 
and functional state of its healthy areas due to the 
released humoral factors. The obtained data give 
opportunities for creation of medicines for treatment 
and prevention of the discussed pathology which 
would have new mechanisms of action. 
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